IRWD
IRONWOOD PHARMACEUTICALS INC
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$4.36
+3.07%Forward multiples
Based on analyst estimates
- P/E forward
- 3.45x
- P/E 2026E
- 3.53x
- P/E 2027E
- 3.28x
- P/E 2028E
- 3.02x
- P/S forward
- 1.52x
Trailing multiples
Trailing twelve months
- P/E TTM
- 5.48x
- PEG TTM
- 0.09x
- Price / book
- -4.45x
- Price / sales
- 1.85x
- Price / cash flow
- 3.88x
Enterprise value
- Enterprise value
- $1.0B
- EV / sales
- 2.67x
- EV / EBITDA
- 4.30x
- EV / EBIT
- 4.40x
- Market cap
- $720.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026